The first EU TRAIN – ESOT symposium is a unique opportunity to “get on board” the EU-TRAIN, the European Transplantation and Innovation Consortium for Risk Stratification in Kidney Transplant Patients. The symposium will not only introduce the consortium, but it will also focus on the methodological and statistical pitfalls clinical researchers can face in the field of transplantation.
At the symposium that takes place on Sunday 15 September 2019, the future of biomarker-guided patient care in solid organ transplantation will be further exposed as well as how the consortium will create a molecular platform for precision diagnostics, data integration and analytics. Eventually, it will provide a platform of discussion on how to network and set up a European Consortium specifically directed to the younger audience.
To promote a better representation from different countries in Europe, ESOT is supporting travel costs and offering a complimentary congress registration to two young transplant professionals under 40 years of age.
Applicants are invited to send their view on “What makes great collaborations in medical research?” (max 500 words)
The text must be submitted by 30 June 2019 to the following email: firstname.lastname@example.org. Submitted essays will be reviewed by an EU-TRAIN committee and winners will be notified by 17 July 2019. The travel support will be awarded on-site at the congress.
For more information on the EU-TRAIN project visit http://eu-train-project.eu/.
The session features presentations by:
Carmen Lefaucheur received her qualification as Nephrologist in 2004 from Paris Descartes University. She defended her Ph.D. in Biology and Biotechnology in 2012.
He defended his M.D. in 2014 and obtained the Resident Award of Paris Hospitals. He also defended his Ph.D. in biostatistics and epidemiology in 2017 in the Paris Translational Research Center for Organ Transplantation.
Dr Oriol Bestard is the head of the Kidney transplant program at Bellvitge University Hospital and Associate Professor at Barcelona University (UB). He developed part of his Phd graduate at the Transplant Immunology Center at The Charité (Berlin, Germany) and completed a post-doctoral stage at the Multiorgan Transplant Research Laboratory at the University of California San Francisco (UCSF, US).
He defended his M.D. in 2008 and obtained the Resident Award of Paris Hospitals.
He defended his Ph.D. in basic science in 2011 and obtained a Ph.D. in biostatistics in 2014.
| Yassine Bouatou
Dr. Yassine Bouatou defended his M.D in 2016 in Geneva, Switzerland. He will defend his Ph.D. in Transplant Immunopathology from the University of Amsterdam, in 2019.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 754995.